In T2D, FMT lowers systemic inflammation by reducing pro-inflammatory cytokines (TNF-α, IL-6) and lipopolysaccharide (LPS) translocation, thereby improving insulin sensitivity [12]. Here, INS is linked to type 2 diabetes mellitus.